Advocacy intelligence hub — real-time data for patient organizations
Boehringer Ingelheim — PHASE3
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company — PHASE3
University Hospital, Montpellier — PHASE2
Quell Therapeutics Limited — PHASE1, PHASE2
Beijing Boren Hospital — EARLY_PHASE1
Beijing GoBroad Hospital — PHASE1, PHASE2
Tongji Hospital — NA
Stephan Grupp MD PhD — PHASE2
Galderma R&D — PHASE2
Mediar Therapeutics — PHASE2
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Dinesh Khanna, MD, MS, M.D
University of Michigan
📍 THE VILLAGES, FL
Robert Spiera, MD, MD
Hospital for Special Surgery, New York
📍 NEW YORK, NY
Julia Spierings
UMC Utrecht
Robyn T Domsic, MD
University of Pittsburgh
📍 PITTSBURGH, PA
Janet E Pope, PhD, RDCS
University of Western Ontario, Division of Rheumatology, St. Joseph's Health Care, London, Ontario, Canada
📍 HAMPTON, VA
Janet E Pope, RDCS
Division of Rheumatology, Department of Medicine, Western University
📍 HAMPTON, VA